Daily Ards Research Analysis
Analyzed 3 papers and selected 3 impactful papers.
Summary
Across ARDS-related literature today: a multicenter post hoc analysis maps wide inter-country variability in neuromuscular blocker use for acute brain injury and links it to neuromonitoring practices; a perspective argues lung-protective ventilation is not sex neutral and may disadvantage females; and a rare toxicology case details delayed ARDS with sepsis-associated DIC after aluminium phosphide ingestion, emphasizing vigilant monitoring and protocolized care.
Research Themes
- Neuromuscular blockade and ventilation strategies in neurocritical care
- Sex-specific considerations in lung-protective ventilation for ARDS
- Toxicology-induced ARDS with coagulopathy
Selected Articles
1. Utilization of Neuromuscular Blocking Agents in Acute Brain Injury and Associations with Outcomes: A Post Hoc Analysis of the ENIO Study.
In a post hoc analysis of the multicenter ENIO cohort, 258 propensity-matched ABI patients showed NMBA use in 33.3% during the first ICU week, with country-level utilization ranging from 0% to 59.3%. NMBA use was associated with intraparenchymal ICP monitoring (OR 2.06) and extraventricular drain placement (OR 2.18), and was most common in patients with ICP monitoring or moderate-to-severe ARDS, underscoring the need for randomized trials.
Impact: This multicenter propensity-matched analysis addresses a major evidence gap on NMBA practice in acute brain injury and links use to neuromonitoring practices, informing future trials and standardization.
Clinical Implications: Until RCTs clarify causal effects, clinicians should apply NMBA selectively (e.g., severe ARDS, refractory ventilator dyssynchrony, ICP crises) with close neuromonitoring and standard lung-protective ventilation, recognizing wide practice variability.
Key Findings
- Across countries, NMBA utilization ranged from 0% to 59.3%.
- In the matched cohort (n=258), 33.3% received NMBA during the first ICU week.
- NMBA use was associated with intraparenchymal ICP monitoring (OR 2.06; 95% CI 1.16–3.76) and extraventricular drain placement (OR 2.18; 95% CI 1.18–4.05).
- NMBA were most commonly used in patients with ICP monitoring or moderate-to-severe ARDS; outcome associations require RCTs.
Methodological Strengths
- Multicenter prospective observational design with predefined inclusion criteria
- Propensity score matching and multivariable regression to address confounding
Limitations
- Post hoc observational analysis susceptible to residual confounding
- Heterogeneity in practice across countries and relatively small matched sample size
Future Directions: Pragmatic RCTs testing standardized NMBA protocols in ABI, stratified by ARDS severity and neuromonitoring, with shared data to enhance reproducibility.
BACKGROUND: Neuromuscular blocking agents (NMBA) have been used in mechanically ventilated patients with moderate-to-severe acute respiratory distress syndrome (ARDS), in cases of clinically significant ventilator dyssynchrony, and in patients with elevated intracranial pressure (ICP). However, practice patterns around NMBA utilization and their impact on outcomes in acute brain injury (ABI) remain insufficiently explored. METHODS: This study carried out a post hoc analysis of a multicenter, prospective observational study (NCT03400904) including adult patients with ABI (Glasgow Coma Scale ≤ 12 before intubation) who required invasive mechanical ventilation (IMV) ≥ 24 h. Patients who received NMBA during their first week of ICU stay were propensity matched to those who did not. RESULTS: Propensity score matching was performed in 1482 patients; among the matched cohort (n = 258), 33.3% (n = 86) received NMBA. NMBA utilization varied from 0% to 59.3% across countries. Multivariable regressions demonstrated associations between NMBA use and utilization of intraparenchymal ICP monitoring (odds ratio, OR 2.06; 95% confidence interval, CI 1.16-3.76), extraventricular drain placement (OR 2.18; 95% CI 1.18-4.05), higher PaCO CONCLUSIONS: NMBA utilization varied widely, highlighting the need for more evidence to guide clinical practice. NMBA were most commonly used in patients with ICP monitoring or moderate-to-severe ARDS; associations with outcomes warrant further exploration in randomized controlled trials.
2. Lung-protective mechanical ventilation is not sex neutral.
This perspective argues that lung-protective ventilation is not sex neutral: females with ARDS have higher mortality and are less likely to receive low tidal volumes due to height-related and estimation errors. It also posits that sex-based physiologic and management differences may reduce effectiveness in females, calling for sex-aware protocols and precise height measurement.
Impact: By synthesizing evidence on sex disparities in ARDS ventilation, it challenges assumptions of sex neutrality and highlights actionable system changes (e.g., measured height, PBW-based tidal volumes).
Clinical Implications: Implement measured height for all ventilated patients, calculate PBW to set tidal volume, audit for sex-based underuse of lung-protective ventilation, and consider sex-aware adjustments in sedation, proning, and adjuncts.
Key Findings
- Females with ARDS have higher mortality than males.
- Females are less likely to receive lung-protective ventilation due to shorter height and errors from visually estimated height.
- Physiologic and extrapulmonary sex differences may reduce effectiveness of lung-protective ventilation in females.
Methodological Strengths
- Integrates clinical outcomes and physiologic considerations to frame a sex-specific hypothesis
- Highlights multiple, testable system-level contributors (e.g., height measurement practices)
Limitations
- Narrative perspective without systematic methods or new primary data
- Causality and effect sizes are not quantified
Future Directions: Prospective studies and RCTs to evaluate sex-specific ventilatory targets and to implement accurate height/PBW workflows with audit-feedback.
Ventilator-induced lung injury can be mitigated with a lung-protective ventilation strategy that includes ventilation with low tidal volumes. Mortality in acute respiratory distress syndrome (ARDS) remains higher in females than in males, and females with ARDS are less likely to receive lung-protective ventilation compared with males because of their shorter height and greater error when body height is visually estimated. In addition, lung-protective ventilation might be less effective in females because of differences in respiratory physiology not accounted for by the formula commonly used to assess body weight, and because of several clinically important sex-specific differences in extrapulmonary biology and management of critical illness.
3. Delayed acute respiratory distress syndrome and sepsis-associated disseminated intravascular coagulation following aluminium phosphide poisoning.
An adolescent ingesting ~1.5 g aluminium phosphide developed delayed moderate ARDS at 72–96 hours, preceded by culture-proven infections and complicated by sepsis-associated DIC. She required escalation to invasive ventilation and comprehensive supportive care and recovered fully, emphasizing vigilance for delayed lung injury after initially stable poisoning.
Impact: This rare, well-documented case delineates a delayed ARDS phenotype with sepsis-associated coagulopathy after aluminium phosphide poisoning, informing surveillance and supportive management in toxicology ICUs.
Clinical Implications: Monitor aluminium phosphide poisoning patients closely for 72–96 hours for evolving hypoxemia and infection; apply lung-protective ventilation, targeted antimicrobials, DIC component therapy, and early magnesium/calcium supplementation.
Key Findings
- Following ~1.5 g aluminium phosphide ingestion, delayed moderate ARDS (PaO2/FiO2 ≈115 on FiO2 1.0) developed at 72–96 hours.
- Fever and culture-proven lower respiratory and urinary infections led to sepsis and DIC.
- Escalation to invasive ventilation with lung-protective strategies plus targeted antibiotics and component therapy resulted in full recovery despite elevated NT-proBNP and transient AKI.
Methodological Strengths
- Detailed temporal clinical course with objective diagnostics (cultures, echocardiography, oxygenation indices)
- Clear description of ventilation and supportive strategies
Limitations
- Single-patient case limits generalizability
- Causal attribution between phosphide exposure and ARDS is confounded by concomitant infections
Future Directions: Establish registries/case series for aluminium phosphide poisoning to characterize delayed lung injury and coagulopathy; explore mechanisms of phosphine-induced pulmonary toxicity.
Aluminium phosphide is a highly lethal pesticide that liberates phosphine gas, leading to mitochondrial dysfunction, distributive shock and cardiotoxicity, but guidance on late pulmonary complications is limited. We report a previously healthy adolescent who ingested ~1.5 g of aluminium phosphide in a suicide attempt and initially presented haemodynamically stable with metabolic acidosis and elevated lactate. By 72-96 hours, she developed progressive hypoxemic respiratory failure with bilateral infiltrates fulfilling Berlin criteria for moderate acute respiratory distress syndrome (ARDS) (PaO₂/FiO₂ nadir ≈115 on FiO₂ 1.0), preceded by fever and culture-proven lower respiratory and urinary tract infections, resulting in sepsis and disseminated intravascular coagulation (DIC). She required escalation from non-invasive to invasive mechanical ventilation, with lung-protective strategies, targeted antibiotics, component therapy for DIC and early magnesium and calcium supplementation. Despite markedly elevated N-terminal pro-B-type natriuretic peptide with preserved biventricular function on echocardiography and transient acute kidney injury, she made a full clinical recovery and was discharged with normal oxygenation and functional status. This case underscores that delayed moderate ARDS with superimposed sepsis and DIC can complicate initially stable aluminium phosphide poisoning and highlights that meticulous, protocol-based supportive care can still result in survival in this rarely reported scenario.